Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities

被引：0
|
作者：
Zhou, Cindy Ke [1 ]
Yasui, Daisaku [1 ]
Yoshinaga, Eiko [1 ]
Pearce, Kristina [1 ]
Martin, David [1 ]
Esposito, Daina B. [1 ]
Kubo, Tadamichi [1 ]
机构：
[1] Moderna Inc, Cambridge, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
649
引用
收藏
页码：274 / 275
页数：2
相关论文
共 50 条
  • [1] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    NEUROLOGY, 2022, 98 (18)
  • [2] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [3] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Hirotsugu Uemura
    Yoshihiko Tomita
    Norio Nonomura
    Kenji Yoshizaki
    Takafumi Nakao
    Nobuo Shinohara
    International Journal of Clinical Oncology, 2022, 27 : 1061 - 1067
  • [4] Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance
    Uemura, Hirotsugu
    Tomita, Yoshihiko
    Nonomura, Norio
    Yoshizaki, Kenji
    Nakao, Takafumi
    Shinohara, Nobuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (06) : 1061 - 1067
  • [5] Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan
    Takayama, Koichi
    Kojima, Ai
    Honda, Chikara
    Nakayama, Masahiro
    Kanemata, Satomi
    Endo, Toshimitsu
    Muro, Kei
    CANCER MEDICINE, 2024, 13 (09):
  • [6] Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study
    Fujimoto, Nobukazu
    Akamatsu, Ayumi
    Honda, Chikara
    Aoki, Miki
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [7] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
    Nakamura, S.
    Asano, T.
    Tanaka, Y.
    Sugimoto, K.
    Yoshigoe, S.
    Suzuki, Y.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
  • [8] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
    Nakamura, S.
    Asano, T.
    Tanaka, Y.
    Sugimoto, K.
    Yoshigoe, S.
    Suzuki, Y.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
  • [9] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Tahara, Makoto
    Kiyota, Naomi
    Nibu, Ken-ichi
    Akamatsu, Ayumi
    Hoshino, Tomohiro
    Hayashi, Ryuichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1619 - 1627
  • [10] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Makoto Tahara
    Naomi Kiyota
    Ken-ichi Nibu
    Ayumi Akamatsu
    Tomohiro Hoshino
    Ryuichi Hayashi
    International Journal of Clinical Oncology, 2021, 26 : 1619 - 1627
12345